Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A13462 | 29960159 | Nutrition | Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy. | 2018 | Details |
A13464 | 29959418 | Lab Invest | Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water. | 2018 | Details |
A13465 | 29959134 | Drug Metab Dispos | Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation. | 2018 | Details |
A13466 | 29958960 | J Ethnopharmacol | The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice. | 2018 | Details |
A13478 | 29956205 | Adv Exp Med Biol | Chemokines and Chemokine Receptors in the Development of NAFLD. | 2018 | Details |
A13479 | 29956204 | Adv Exp Med Biol | Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. | 2018 | Details |
A13486 | 29954129 | Int J Mol Sci | Insights into the Role of PPARβ/δ in NAFLD. | 2018 | Details |
A13504 | 29945982 | J Endocrinol | INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. | 2018 | Details |
A13540 | 29924135 | Braz J Med Biol Res | Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. | 2018 | Details |
A13546 | 29920654 | Clin Exp Immunol | Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. | 2018 | Details |
A13553 | 29913436 | Cell Physiol Biochem | NEFA-Sensitive Orai1 Expression in Regulation of De Novo Lipogenesis. | 2018 | Details |
A13565 | 29907965 | Hepatology | The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice. | 2018 | Details |
A13574 | 29902065 | Am J Physiol Gastrointest Liver Physiol | Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice. | 2018 | Details |
A13576 | 29898759 | J Hematol Oncol | Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. | 2018 | Details |
A13577 | 29898626 | Adipocyte | Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance. | 2018 | Details |
A13583 | 29895370 | J Trace Elem Med Biol | Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-An immunohistochemical study. | 2018 | Details |
A13594 | 29890136 | Biochem Biophys Res Commun | Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice. | 2018 | Details |
A13596 | 29889226 | Inflamm Bowel Dis | Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography. | 2019 | Details |
A13601 | 29883724 | Chem Biol Interact | Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway. | 2018 | Details |
A13606 | 29881817 | Hepatol Commun | Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage. | 2018 | Details |
A13629 | 29864471 | Toxicol In Vitro | Treatment of cigarette smoke extract and condensate differentially potentiates palmitic acid-induced lipotoxicity and steatohepatitis in vitro. | 2018 | Details |
A13632 | 29861476 | Nutrients | IDH2 Deficiency Aggravates Fructose-Induced NAFLD by Modulating Hepatic Fatty Acid Metabolism and Activating Inflammatory Signaling in Female Mice. | 2018 | Details |
A13638 | 29860102 | J Nutr Biochem | Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet. | 2018 | Details |
A13641 | 29859019 | Br J Pharmacol | A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway. | 2018 | Details |
A13644 | 29858567 | Nat Commun | Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. | 2018 | Details |
A13655 | 29854715 | Can J Gastroenterol Hepatol | Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. | 2018 | Details |
A13656 | 29853957 | Evid Based Complement Alternat Med | Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13659 | 29852170 | Biochem Biophys Res Commun | Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. | 2018 | Details |
A13668 | 29847555 | PLoS One | Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH. | 2018 | Details |
A13673 | 29845362 | Wien Klin Wochenschr | Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. | 2018 | Details |
A13675 | 29845121 | Open Med (Wars) | Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease. | 2018 | Details |
A13676 | 29844879 | Oncotarget | Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2018 | Details |
A13680 | 29843959 | Trends Immunol | Liver-Microbiome Axis in Health and Disease. | 2018 | Details |
A13686 | 29805971 | Int J Chronic Dis | Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. | 2018 | Details |
A13698 | 29802679 | J Diabetes Investig | Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis. | 2018 | Details |
A13703 | 29800810 | J Nutr Biochem | Consumption of conjugated linoleic acid (CLA)-supplemented diet during colitis development ameliorates gut inflammation without causing steatosis in mice. | 2018 | Details |
A13706 | 29799627 | J Periodontol | Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis. | 2018 | Details |
A13710 | 29797516 | Eur J Clin Invest | Exercising the hepatobiliary-gut axis. The impact of physical activity performance. | 2018 | Details |
A13725 | 29789866 | Cell Mol Life Sci | Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. | 2018 | Details |
A13727 | 29788077 | Inflamm Bowel Dis | IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease. | 2018 | Details |
A13735 | 29785077 | World J Gastroenterol | Mediterranean diet and nonalcoholic fatty liver disease. | 2018 | Details |
A13743 | 29779210 | J Clin Periodontol | The association between missing teeth and non-alcoholic fatty liver disease in adults. | 2018 | Details |
A13744 | 29779170 | Eur J Nutr | Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. | 2018 | Details |
A13746 | 29778532 | Biochem Biophys Res Commun | Non-alcoholic fatty liver disease: Insights from sphingolipidomics. | 2018 | Details |
A13767 | 29766801 | Curr Pharm Biotechnol | Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective. | 2018 | Details |
A13768 | 29766791 | Curr Pharm Des | Immunometabolic Changes in Hepatocytes Arising from Obesity and the Practice of Physical Exercise. | 2018 | Details |
A13780 | 29761170 | Hepatol Commun | Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. | 2018 | Details |
A13781 | 29760679 | Front Endocrinol (Lausanne) | Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2018 | Details |
A13783 | 29760499 | Sci Rep | Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. | 2018 | Details |
A13789 | 29756964 | Nutr Hosp | Açai improves non-alcoholic fatty liver disease (NAFLD) induced by fructose. | 2018 | Details |
A13797 | 29751074 | Food Chem Toxicol | Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice. | 2018 | Details |
A13800 | 29749323 | Turk J Gastroenterol | Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13805 | 29747118 | J Nutr Biochem | Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice. | 2018 | Details |
A13806 | 29746920 | Biochim Biophys Acta Mol Basis Dis | Animal models of NAFLD from the pathologist's point of view. | 2018 | Details |
A13819 | 29743560 | Cell Death Differ | Caspases in metabolic disease and their therapeutic potential. | 2018 | Details |
A13821 | 29743187 | Mol Pharmacol | Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation. | 2018 | Details |
A13829 | 29735977 | Cell Mol Immunol | Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. | 2018 | Details |
A13831 | 29735799 | Ann Hepatol | Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway. | 2018 | Details |
A13843 | 29729191 | Hepatology | Caspase Recruitment Domain Protein 6 Protects Against Hepatic Steatosis and Insulin Resistance by Suppressing Apoptosis Signal-Regulating Kinase 1. | 2018 | Details |
A13847 | 29729104 | Liver Transpl | The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. | 2018 | Details |
A13866 | 29719629 | Oncotarget | Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1. | 2018 | Details |
A13867 | 29719598 | Oncotarget | Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver. | 2018 | Details |
A13869 | 29718361 | Toxicol Sci | Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis. | 2018 | Details |
A13879 | 29713125 | World J Gastroenterol | Beneficial effects of naringenin in liver diseases: Molecular mechanisms. | 2018 | Details |
A13883 | 29710765 | Nutrients | A Vitamin E-Enriched Antioxidant Diet Interferes with the Acute Adaptation of the Liver to Physical Exercise in Mice. | 2018 | Details |
A13884 | 29710519 | Biomed Pharmacother | Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. | 2018 | Details |
A13889 | 29707653 | Wellcome Open Res | Methyl donor deficient diets cause distinct alterations in lipid metabolism but are poorly representative of human NAFLD. | 2017 | Details |
A13893 | 29705240 | J Hepatol | CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. | 2018 | Details |
A13898 | 29704259 | Hepatology | TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. | 2018 | Details |
A13902 | 29701903 | Mol Nutr Food Res | Impact of miR-140 Deficiency on Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A13912 | 29697458 | Eur J Gastroenterol Hepatol | Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis. | 2018 | Details |
A13914 | 29696816 | J Dig Dis | Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression. | 2018 | Details |
A13921 | 29690903 | J Transl Med | CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. | 2018 | Details |
A13922 | 29690638 | Nutrients | Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity. | 2018 | Details |
A13924 | 29688336 | Inflamm Bowel Dis | Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. | 2018 | Details |
A13927 | 29686465 | World J Gastroenterol | Ultrasound findings in autoimmune hepatitis. | 2018 | Details |
A13929 | 29684027 | PLoS One | Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. | 2018 | Details |
A13938 | 29679615 | Metabolism | Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress. | 2018 | Details |
A13943 | 29678641 | Biochim Biophys Acta Mol Cell Biol Lipids | Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. | 2018 | Details |
A13955 | 29672963 | Biofactors | Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. | 2018 | Details |
A13956 | 29672926 | J Gastroenterol Hepatol | Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas. | 2018 | Details |
A13961 | 29670908 | Biomed Res Int | Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis. | 2018 | Details |
A13965 | 29666185 | J Biol Chem | Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. | 2018 | Details |
A13966 | 29666152 | J Endocrinol | Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD. | 2018 | Details |
A13967 | 29665983 | Trends Mol Med | IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies. | 2018 | Details |
A13969 | 29665135 | Hepatology | Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13973 | 29662454 | Front Physiol | The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis. | 2018 | Details |
A13980 | 29660503 | Redox Biol | High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease. | 2018 | Details |
A13987 | 29656250 | Environ Pollut | Exposure to environmental level phenanthrene induces a NASH-like phenotype in new born rat. | 2018 | Details |
A13994 | 29653359 | J Nutr Biochem | The role of the gut microbiota in the pathology and prevention of liver disease. | 2018 | Details |
A13996 | 29653100 | Chem Biol Interact | Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet. | 2018 | Details |
A13997 | 29652567 | J Am Coll Nutr | A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial. | 2018 | Details |
A14007 | 29641459 | Molecules | An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A14016 | 29633106 | Inflammopharmacology | Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate. | 2018 | Details |
A14021 | 29631332 | Hepatology | Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. | 2018 | Details |
A14024 | 29629626 | Expert Rev Gastroenterol Hepatol | The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. | 2018 | Details |
A14029 | 29627620 | Contemp Clin Trials | Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design. | 2018 | Details |
A14034 | 29623674 | J Gastrointest Surg | Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. | 2018 | Details |
A14042 | 29620148 | Int J Mol Med | Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. | 2018 | Details |
A14053 | 29608898 | Eur J Pharmacol | Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation. | 2018 | Details |